N8 Medical Inc is a clinical-stage biotech company based in Park City, UT, specializing in the prevention and treatment of biofilm-related hospital acquired infections and Cystic Fibrosis. Their innovative platform technology combines device and drug applications to address these potentially deadly conditions.
With a focus on preventing Ventilator Associated Pneumonia, N8 Medical's lead product aims to tackle a significant healthcare challenge. Their ceragenins, small molecule mimetics of antimicrobial peptides, have been extensively researched and have garnered attention with over 100 peer-reviewed journal articles. N8 Medical is committed to making a positive impact in the medical field by addressing the high costs and mortality rates associated with hospital acquired infections in the United States.
Generated from the website